Envoya

EnvoyaEnvoya
Envoya

Envoya

Developing polymer-based nanoparticles for targeted gene therapy delivery.

DR 142021Active10San Diego, United States
Rate

About

Envoya is an AI-powered biomedical technology company developing next-generation gene delivery systems. They create polymer-based nanoparticles using FDA-approved materials for safer and more effective delivery of genetic material, enabling groundbreaking treatments for various diseases. Envoya serves academic institutions and pharmaceutical companies seeking to overcome gene therapy's delivery barriers.
Frequently asked

What does Envoya do?

Envoya is an AI-powered biomedical technology company developing next-generation gene delivery systems. They create polymer-based nanoparticles using FDA-approved materials for safer and more effective delivery of genetic material, enabling groundbreaking treatments for various diseases. Envoya serves academic institutions and pharmaceutical companies seeking to overcome gene therapy's delivery barriers.

What is Envoya's revenue?

StartupHub estimates Envoya's annual revenue at $1.7M (range $953K to $2.7M, 64% confidence), based on comparable companies in the sector.

What is Envoya's valuation?

StartupHub estimates Envoya's effective valuation at $7.4M (range $5.0M to $12.0M, 12% confidence), based on comparable companies in the sector.

How much funding has Envoya raised?

Envoya has raised a total of $2M in funding. The most recent round on record is Pre-Seed.

Where is Envoya headquartered?

Envoya is headquartered in San Diego, United States.

When was Envoya founded?

Envoya was founded in 2021.

What industry does Envoya operate in?

Envoya operates in Life Sciences, Nanotechnology, Genetics, Biotech, Drug Delivery, MedTech.

How many employees does Envoya have?

Envoya has approximately 10 people on record.

HEADCOUNT
10
DOMAIN RATING
14
Comments

No comments yet. Be the first to share your take.